CFO appointment
Oragenics, Inc. appoints John Spencer as CFO
Oragenics, Inc. reported in a Form 8-K filed July 6, 2026 that John Spencer was appointed Chief Financial Officer, effective July 1, 2026.
In the filing's words
Effective July 1, 2026, the Board appointed John Spencer, the Company’s Senior Controller, to serve as the Company’s Chief Financial Officer.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | Oragenics, Inc. (OGEN) |
|---|---|
| Event | Appointment |
| Incoming | John Spencer |
| Title in the filing | Chief Financial Officer |
| Effective | July 1, 2026 |
| 8-K filed | July 6, 2026 |
| Internal promotion | Yes |
| Prior role (per filing) | Senior Controller, ORAGENICS INC |
| SEC CIK | 0001174940 |
Oragenics, Inc. reported this change in a Form 8-K, Item 5.02, filed July 6, 2026. The filing's own words are quoted above.
Same industry, July 2026
7Other moves filed that month at companies the roster files under SIC “Pharmaceutical Preparations”.
3 months ago· 2026-07-31AppointmentGCAN
The Greater Cannabis Company, Inc. appoints Michelle Cervantes Vivanco as CFO
3 months ago· 2026-07-28TransitionVYNE
Yarrow Bioscience, Inc. CFO transition: Tyler Zeronda to succeed Mutya Harsch
3 months ago· 2026-07-22InterimKROS
Keros Therapeutics, Inc. names Annita Tanini interim CFO
3 months ago· 2026-07-20AppointmentPMHS
Polomar Health Services, Inc. appoints Douglas Beck as CFO
4 months ago· 2026-07-13AppointmentMBX
MBX Biosciences, Inc. appoints John Smither as CFO
4 months ago· 2026-07-08TransitionOVID
Ovid Therapeutics Inc. CFO transition: Charles Carter to succeed Jeffrey Rona
4 months ago· 2026-07-06TransitionLGVN
Longeveron Inc. CFO transition: Marie Washburn to succeed Lisa Locklear
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about John Spencer? Send a correction with the primary source.